Trident Texofab (TTFL) | Stock Overview & Key Data
Trident Texofab Performance Comparison
Stock Range
Today's Range
Low: ₹211.25
High: ₹217.20
on August 8, 2025
52 Week Range
Low: ₹42.01
High: ₹220.00
on August 14, 2024
on June 27, 2025
All-Time High: ₹220.00 on June 23, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR3.2B
EPS
2.08
P/E Ratio (TTM)
103.63
Forward P/E
N/A
P/B Ratio
4.66
PEG Ratio
N/A
Div. Yield
N/A
ROE
7.91%
Beta
-1.445
Debt to Equity
62.67
Financial Highlights
Profitability
Gross Margin
14.02%
Operating Margin
2.47%
Profit Margin
2.06%
Returns and Earnings
Return on Assets (TTM)
2.62%
Return on Equity (TTM)
7.91%
EBITDA
INR87.7M
Net Income (TTM)
INR25.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR90.02
Quarterly Revenue Growth (YoY)
26.60%
Quarterly Earnings Growth (YoY)
26.63%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Trident Texofab TTFL | 3.23B Small-cap | 0.35% | -0.39% | 12.43% | 30.09% | 25.24% | 384.01% | 79.12% | 414.00% |
| KPR Mill KPRMILL | 347.59B Large-cap | -7.72% | -18.58% | -17.16% | 10.61% | -0.43% | 10.03% | 71.05% | 816.69% |
| Trident TRIDENT | 145.17B Mid-cap | -4.22% | -14.28% | -0.50% | -6.77% | -18.25% | -26.93% | -26.38% | 313.13% |
| Raymond RAYMOND | 42.00B Small-cap | -5.80% | -12.52% | -59.83% | -58.60% | -63.47% | -67.76% | -33.91% | 131.17% |
| Sanathan Textiles SANATHAN | 41.60B Small-cap | -7.32% | -9.80% | 9.24% | 32.09% | 27.23% | 20.42% | 20.42% | 20.42% |
| Jindal Worldwide JINDWORLD | 35.60B Small-cap | -10.22% | -25.53% | -44.64% | -55.87% | -58.05% | -51.84% | -18.17% | 286.29% |
Ownership & Short Interest
Insider Ownership
37.04%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
8K
Average 90-Day Volume
21K
Trident Texofab Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Trident Texofab would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is TTFL's 52-week high and low?
- In the last 52 weeks, Trident Texofab reached a high of ₹220.00 (on June 27, 2025) and a low of ₹42.01 (on August 14, 2024).
- What is the market cap and P/E ratio for TTFL?
- Curious about Trident Texofab's size and valuation? Its market capitalization stands at 3.23B. When it comes to valuation, the P/E ratio (trailing twelve months) is 103.63, and the forward P/E (looking ahead) is N/A.
- Does TTFL pay dividends? If so, what's the yield?
- As for dividends, Trident Texofab isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Trident Texofab's main competitors or similar companies to consider before investing?
When looking at Trident Texofab, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return KPR Mill
KPRMILL347.59B Consumer Cyclical Textile Manufacturing 10.03% 71.05% Trident
TRIDENT145.17B Consumer Cyclical Textile Manufacturing -26.93% -26.38% Raymond
RAYMOND42.00B Consumer Cyclical Textile Manufacturing -67.76% -33.91% Sanathan Textiles
SANATHAN41.60B Consumer Cyclical Textile Manufacturing 20.42% 20.42% Jindal Worldwide
JINDWORLD35.60B Consumer Cyclical Textile Manufacturing -51.84% -18.17% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Trident Texofab Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Trident Texofab's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.91%, the Debt to Equity ratio from the most recent quarter is 62.67, and its Gross Profit Margin stands at 14.02%.
- What is the recent revenue and earnings growth for TTFL?
- Looking at Trident Texofab's growth, its revenue over the trailing twelve months (TTM) was INR1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 26.60%, and quarterly earnings saw a YoY growth of 26.63%.
- How much of TTFL stock is held by insiders and institutions?
- Wondering who owns Trident Texofab stock? Company insiders (like executives and directors) hold about 37.04% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.